The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis

Patients with rheumatoid arthritis (RA) are at an increased risk of cardiovascular disease (CVD). Treatment with tumor necrosis factor inhibitors improves both joint symptoms associated with RA and also CVD risk. This exploratory analysis of a phase 4 study evaluated changes in metabolic risk factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Deodhar, Atul, Bitman, Bojena, Yang, Yue, Collier, David H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2016
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118390/
https://www.ncbi.nlm.nih.gov/pubmed/27704313
http://dx.doi.org/10.1007/s10067-016-3422-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118390/
https://www.ncbi.nlm.nih.gov/pubmed/27704313
http://dx.doi.org/10.1007/s10067-016-3422-7

Ejemplares similares